A detailed history of Bellevue Group Ag transactions in Eli Lilly & CO stock. As of the latest transaction made, Bellevue Group Ag holds 44,246 shares of LLY stock, worth $35.2 Million. This represents 0.66% of its overall portfolio holdings.

Number of Shares
44,246
Previous 49,674 10.93%
Holding current value
$35.2 Million
Previous $45 Million 12.84%
% of portfolio
0.66%
Previous 0.75%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $4.19 Million - $5.21 Million
-5,428 Reduced 10.93%
44,246 $39.2 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $6.01 Million - $7.54 Million
-8,291 Reduced 14.3%
49,674 $45 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $1.04 Million - $1.39 Million
1,753 Added 3.12%
57,965 $45.1 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $13.3 Million - $15.7 Million
-25,329 Reduced 31.06%
56,212 $32.8 Million
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $5.92 Million - $8.16 Million
-13,614 Reduced 14.31%
81,541 $43.8 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $29.6 Million - $39.6 Million
84,391 Added 784.01%
95,155 $44.6 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $90,393 - $106,162
-291 Reduced 2.63%
10,764 $3.7 Million
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $503,225 - $586,358
1,565 Added 16.49%
11,055 $4.04 Million
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $2.53 Million - $2.88 Million
8,521 Added 879.36%
9,490 $3.07 Million
Q2 2022

Aug 11, 2022

BUY
$278.73 - $327.27 $270,089 - $317,124
969 New
969 $314,000
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $1.77 Million - $2.2 Million
-7,552 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $1.7 Million - $2.11 Million
7,552 New
7,552 $2.09 Million
Q1 2018

May 09, 2018

SELL
$74.21 - $87.6 $17.9 Million - $21.1 Million
-241,262 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$77.07 - $85.54 $4.64 Million - $5.15 Million
60,189 Added 33.24%
241,262 $20.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
181,073
181,073 $14.9 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Bellevue Group Ag Portfolio

Follow Bellevue Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.